Petri M - Search Results

1

Hydroxychloroquine use in the Baltimore Lupus Cohort: effects on lipids, glucose and thrombosis.

Petri M. Petri M. Lupus. 1996 Jun;5 Suppl 1:S16-22. Lupus. 1996. PMID: 8803905 Review.

2

Urine peptidomic biomarkers for diagnosis of patients with systematic lupus erythematosus.

Pejchinovski M, Siwy J, Mullen W, Mischak H, Petri MA, Burkly LC, Wei R. Pejchinovski M, et al. Among authors: petri ma. Lupus. 2018 Jan;27(1):6-16. doi: 10.1177/0961203317707827. Epub 2017 May 5. Lupus. 2018. PMID: 28474961 Free PMC article.

3

Assessments of fatigue and disease activity in patients with systemic lupus erythematosus enrolled in the Phase 2 clinical trial with blisibimod.

Petri MA, Martin RS, Scheinberg MA, Furie RA. Petri MA, et al. Lupus. 2017 Jan;26(1):27-37. doi: 10.1177/0961203316654767. Epub 2016 Jun 26. Lupus. 2017. PMID: 27353505 Clinical Trial.

4

The American College of Rheumatology and the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus in two multiethnic cohorts: a commentary.

Pons-Estel GJ, Wojdyla D, McGwin G Jr, Magder LS, Petri MA, Pons-Estel BA; Grupo Latino Americano De Estudio del Lupus (GLADEL), Alarcón GS; LUMINA cohort. Pons-Estel GJ, et al. Among authors: petri ma. Lupus. 2014;23(1):3-9. doi: 10.1177/0961203313512883. Epub 2013 Nov 27. Lupus. 2014. PMID: 24285098

5

Assessing disease activity in SLE patients during pregnancy.

Buyon JP, Kalunian KC, Ramsey-Goldman R, Petri MA, Lockshin MD, Ruiz-Irastorza G, Khamashta M. Buyon JP, et al. Among authors: petri ma. Lupus. 1999;8(8):677-84. doi: 10.1191/096120399680411272. Lupus. 1999. PMID: 10568906 No abstract available.

6

Safety profile of belimumab: pooled data from placebo-controlled phase 2 and 3 studies in patients with systemic lupus erythematosus.

Wallace DJ, Navarra S, Petri MA, Gallacher A, Thomas M, Furie R, Levy RA, van Vollenhoven RF, Cooper S, Zhong ZJ, Freimuth W, Cervera R; BLISS-52 and -76, and LBSL02 Study Groups. Wallace DJ, et al. Among authors: petri ma. Lupus. 2013 Feb;22(2):144-54. doi: 10.1177/0961203312469259. Epub 2012 Dec 4. Lupus. 2013. PMID: 23213069 Clinical Trial.

7

Genetic association of CD247 (CD3ζ) with SLE in a large-scale multiethnic study.

Martins M, Williams AH, Comeau M, Marion M, Ziegler JT, Freedman BI, Merrill JT, Glenn SB, Kelly JA, Sivils KM, James JA, Guthridge JM, Alarcón-Riquelme ME, Bae SC, Kim JH, Kim D, Anaya JM, Boackle SA, Criswell LA, Kimberly RP, Alarcón GS, Brown EE, Vilá LM, Petri MA, Ramsey-Goldman R, Niewold TB, Tsao BP, Gilkeson GS, Kamen DL, Jacob CO, Stevens AM, Gaffney PM, Harley JB, Langefeld CD, Fesel C. Martins M, et al. Among authors: petri ma. Genes Immun. 2015 Mar;16(2):142-50. doi: 10.1038/gene.2014.73. Epub 2015 Jan 8. Genes Immun. 2015. PMID: 25569266 Free PMC article.

8

A phase 2, randomised, placebo-controlled clinical trial of blisibimod, an inhibitor of B cell activating factor, in patients with moderate-to-severe systemic lupus erythematosus, the PEARL-SC study.

Furie RA, Leon G, Thomas M, Petri MA, Chu AD, Hislop C, Martin RS, Scheinberg MA; PEARL-SC Study. Furie RA, et al. Among authors: petri ma. Ann Rheum Dis. 2015 Sep;74(9):1667-75. doi: 10.1136/annrheumdis-2013-205144. Epub 2014 Apr 19. Ann Rheum Dis. 2015. PMID: 24748629 Clinical Trial.

9

Lupus Atherosclerosis Prevention Study (LAPS).

Petri MA, Kiani AN, Post W, Christopher-Stine L, Magder LS. Petri MA, et al. Ann Rheum Dis. 2011 May;70(5):760-5. doi: 10.1136/ard.2010.136762. Epub 2010 Dec 21. Ann Rheum Dis. 2011. PMID: 21177297 Clinical Trial.

10

Oral candidiasis in systemic lupus erythematosus.

Fangtham M, Magder LS, Petri MA. Fangtham M, et al. Among authors: petri ma. Lupus. 2014 Jun;23(7):684-90. doi: 10.1177/0961203314525247. Epub 2014 Mar 5. Lupus. 2014. PMID: 24598219

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results